Article
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Blood advances - 11 Jan 2022
Bagratuni Tina, Markou Athina, Patseas Dimitrios, Mavrianou-Koutsoukou Nefeli, Aktypi Foteini, Liacos Christine Ivy, Sklirou Aimilia D, Theodorakakou Foteini, Ntanasis-Stathopoulos Ioannis, Gavriatopoulou Maria, Trougakos Ioannis P, Lianidou Evi, Terpos Evangelos, Kastritis Efstathios, Dimopoulos Meletios A
Abstract excerpt
We describe a novel method for the detection of MYD88L265P mutation using a competitive allele-specific polymerase chain reaction (Cast-PCR) assay. This assay has a sensitivity of 1 × 10-3, is applicable in reactions containing very low amounts of DNA (as low as 20 pg), and allowed the detection of MYD88L265P somatic mutation in both tumor-derived DNA (tDNA) and cell-free DNA (cfDNA). In addition, using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
